Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$147M |
| 2 |
NVIDIA
NVDA
|
+$129M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$124M |
| 4 |
SPR
Spirit AeroSystems
SPR
|
+$109M |
| 5 |
INFN
Infinera Corporation Common Stock
INFN
|
+$98.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$97.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$93.9M |
| 3 |
UnitedHealth
UNH
|
+$68.8M |
| 4 |
Salesforce
CRM
|
+$57M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$56.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.46% |
| 2 | Financials | 3.89% |
| 3 | Industrials | 3.8% |
| 4 | Consumer Discretionary | 3.36% |
| 5 | Healthcare | 3.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
CALL
Synchrony
SYF
$26B
| $738K | ﹤0.01% |
+14,800
| New | +$716K |
|
1802
AMN Healthcare
AMN
$1.34B
| $737K | ﹤0.01% |
+17,379
| New | +$911K |
|
|
ZEUS
1803
DELISTED
Olympic Steel
ZEUS
| $736K | ﹤0.01% |
18,881
+11,220
| +146% | +$472K |
|
1804
Crescent Capital BDC
CCAP
$396M
| $732K | ﹤0.01% |
39,555
-46,797
| -54% | -$869K |
|
1805
Essex Property Trust
ESS
$18.9B
| $731K | ﹤0.01% |
+2,476
| New | +$718K |
|
|
AVDL
1806
DELISTED
Avadel Pharmaceuticals
AVDL
| $728K | ﹤0.01% |
+55,525
| New | +$846K |
|
|
NVRO
1807
DELISTED
NEVRO CORP.
NVRO
| $728K | ﹤0.01% |
130,158
+4,152
| +3% | +$29K |
|
1808
CALL
Cigna
CI
$74.1B
| $728K | ﹤0.01% |
+2,100
| New | +$723K |
|
1809
CALL
CarMax
KMX
$8.91B
| $727K | ﹤0.01% |
9,400
-700
| -7% | -$55.4K |
|
1810
PUT
Kimberly-Clark
KMB
$37B
| $726K | ﹤0.01% |
5,100
-1,600
| -24% | -$227K |
|
1811
Mirion Technologies
MIR
$3.66B
| $725K | ﹤0.01% |
65,499
| – | – |
|
1812
Anika Therapeutics
ANIK
$286M
| $725K | ﹤0.01% |
29,342
+715
| +2% | +$18.5K |
|
1813
Intrepid Potash
IPI
$510M
| $725K | ﹤0.01% |
30,195
+6,664
| +28% | +$158K |
|
1814
CALL
BioNTech
BNTX
$28.3B
| $724K | ﹤0.01% |
+6,100
| New | +$561K |
|
1815
CALL
XP
XP
$8.66B
| $723K | ﹤0.01% |
+40,300
| New | +$735K |
|
1816
PUT
Chubb
CB
$133B
| $721K | ﹤0.01% |
2,500
-1,700
| -40% | -$466K |
|
1817
CALL
Norfolk Southern
NSC
$79.3B
| $721K | ﹤0.01% |
+2,900
| New | +$695K |
|
1818
PUT
AerCap
AER
$23.2B
| $720K | ﹤0.01% |
+7,600
| New | +$712K |
|
1819
CALL
Kraft Heinz
KHC
$30.4B
| $720K | ﹤0.01% |
20,500
+8,200
| +67% | +$282K |
|
1820
CALL
Consolidated Edison
ED
$39.8B
| $718K | ﹤0.01% |
+6,900
| New | +$682K |
|
1821
Rivian
RIVN
$24B
| $715K | ﹤0.01% |
+63,732
| New | +$916K |
|
1822
PUT
TransDigm Group
TDG
$66.3B
| $714K | ﹤0.01% |
500
-600
| -55% | -$780K |
|
|
MODV
1823
DELISTED
ModivCare
MODV
| $712K | ﹤0.01% |
+49,838
| New | +$1.14M |
|
1824
GDS Holdings
GDS
$6.36B
| $709K | ﹤0.01% |
+34,777
| New | +$492K |
|
1825
PUT
Roku
ROKU
$23.5B
| $702K | ﹤0.01% |
9,400
-33,500
| -78% | -$2.15M |
|
Similar funds
Paul Tudor Jones's Q3 2024 Portfolio in Review
As of Q3 2024, Paul Tudor Jones held 3,231 positions worth $27.5B, up 41% from $19.5B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Paul Tudor Jones deployed $6.72B of net new capital in Q3 2024, opening 973 new positions and adding to 833 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 686,581 shares worth $152M.
By sector, the portfolio is most concentrated in Technology at 6.5% of assets, down from 8.7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Apple, an estimated $97.9M trimmed.
- Paul Tudor Jones's largest Q3 2024 buy was iShares Russell 2000 ETF: 686,581 shares worth $152M.
- Paul Tudor Jones added most to NVIDIA in Q3 2024, an estimated $129M increase.
- Paul Tudor Jones's biggest Q3 2024 reduction was Apple, cutting an estimated $97.9M.
- Paul Tudor Jones fully exited Bristol-Myers Squibb in Q3 2024, selling an estimated $93.9M.
- Paul Tudor Jones's ten largest holdings make up 47% of its $27.5B portfolio in Q3 2024.
- Paul Tudor Jones opened 973 new positions and closed 594 in Q3 2024.
- Paul Tudor Jones's portfolio value rose 41% quarter-over-quarter to $27.5B.
Based on Tudor Investment Corp's 13F filing for Q3 2024, filed 14 Nov 2024.